C07D 277/30
Radicals substituted by carbon atoms having three bonds to hetero atoms with
Official title: Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
C07D277/30 (Radicals substituted by carbon atoms having three bonds to hetero atoms with) appears on 651 US grants and 591 published applications in this corpus.
Search patents in C07D- Granted patents
- 651
- Published applications
- 591
- Assignees
- 317
- Inventors
- 2,100
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 9 | 0 |
| 1978 | 4 | 0 |
| 1979 | 9 | 0 |
| 1980 | 3 | 0 |
| 1981 | 3 | 0 |
| 1982 | 2 | 0 |
| 1983 | 6 | 0 |
| 1984 | 3 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 0 | 0 |
| 1990 | 3 | 0 |
| 1991 | 5 | 0 |
| 1992 | 7 | 0 |
| 1993 | 16 | 0 |
| 1994 | 10 | 0 |
| 1995 | 12 | 0 |
| 1996 | 23 | 0 |
| 1997 | 29 | 0 |
| 1998 | 25 | 0 |
| 1999 | 19 | 0 |
| 2000 | 14 | 0 |
| 2001 | 16 | 4 |
| 2002 | 16 | 13 |
| 2003 | 16 | 22 |
| 2004 | 13 | 25 |
| 2005 | 11 | 26 |
| 2006 | 13 | 16 |
| 2007 | 14 | 21 |
| 2008 | 9 | 26 |
| 2009 | 23 | 25 |
| 2010 | 13 | 28 |
| 2011 | 16 | 26 |
| 2012 | 19 | 21 |
| 2013 | 26 | 28 |
| 2014 | 23 | 53 |
| 2015 | 32 | 33 |
| 2016 | 37 | 45 |
| 2017 | 33 | 30 |
| 2018 | 20 | 24 |
| 2019 | 18 | 19 |
| 2020 | 12 | 21 |
| 2021 | 13 | 12 |
| 2022 | 11 | 21 |
| 2023 | 7 | 18 |
| 2024 | 16 | 8 |
| 2025 | 7 | 19 |
| 2026 | 7 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compound and method for preventing or treating of respiratory diseases comprising the same as an active ingredient28 Jul 2026US 12,691,101 B2Yonsei University, University—Industry Foundation (Uif)
- Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof26 May 2026US 12,637,436 B2Sanford Burnham Prebys Medical Discovery Institute
- Arylamides and methods of use thereof19 May 2026US 12,630,498 B2Genzyme Corporation
- Refining method31 Mar 2026US 12,590,075 B2NGK Insulators, Ltd.
- Glutamine analogs17 Mar 2026US 12,577,201 B2Jacobio Pharmaceuticals Co., Ltd.
- Probenecid compounds for the treatment of inflammasome-mediated lung disease8 Oct 2026US 2026/0308131 A1Bacainn Biotherapeutics, Ltd.
- Novel indenone derivatives and uses thereof3 Sep 2026US 2026/0256797 A1Amyloid Solution Inc.
- Protease inhibitors for treating or preventing coronavirus infection23 Jul 2026US 2026/0209180 A1Merck Sharp & Dohme Corp.
- Ferroptosis inducers to treat cancer16 Jul 2026US 2026/0199297 A1The University of Toledo
- Probenecid compounds for the treatment of inflammasome-mediated dermatological conditions25 Jun 2026US 2026/0176232 A1Bacainn Biotherapeutics, Ltd.
Most cited
By later US patents
- Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities164US 5,877,207 AAllergan Sales, Inc. · 1999
- Method of identifying negative hormone and/or antagonist activities151US 5,776,699 AAllergan, Inc. · 1998
- Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities134US 5,958,954 AAllergan Sales, Inc. · 1999
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994
- Retroviral protease inhibiting compounds94US 5,541,206 AAbbott Laboratories · 1996